Francesco Conti’s Post

▶ Let's push further the LinkedIn announcement of new jobs… I'm thrilled to share that I’ve started a new position as Chief of Staff at GENFIT! "What is Genfit?" Great question, my dear LinkedIn friends: ● One of the few biotech companies in history to develop a molecule in-house and bring it all the way to market approval. ● 25 years of history, headquartered in Lille, with unique expertise in liver diseases. ● Multiple assets in the pipeline between preclinical trials and Phase 2, focusing on a rare condition: Acute-on-Chronic Liver Failure (ACLF) – a critical unmet need with no current therapies. ● A proven resilience story: after a setback in Phase 3 for NASH, Genfit achieved market approval for treating primary biliary cholangitis (PBC). ● Dual listed on NASDAQ and EURONEXT. ● A highly skilled and trained management team. "That sounds amazing! But what exactly does a Chief of Staff do?" Well, I’d love to spill the details, but that might break confidentiality 😛 What I can share is that I’ll be one of the people connecting the dots, supporting the executive committee, and doing what I’ve loved in the last 5 years in strategy consulting: being involved in Life Sciences decision-making processes to bring solutions to patients and society. Please find attached a nice picture from Lille with cool sunglasses. Follow GENFIT for more insights, and I look forward to seeing you soon! ✨

Curious about the future of Medical Affairs in EMEA (Europe, Middle east and Africa)? Get ready to dive into the heart of innovation and collaboration at MAPS EMEA 2024 Annual meeting!   Join us as Charlotte Kremer MD MBA, CMO of MAPS, shares her insights on what's in store for this year's conference in Madrid. Here's a sneak peek at what she has to say:   What's the Focus of MAPS EMEA 2024? Why will Medical Affairs improve with THIS Conference? How can we do things differently AFTER the Conference?   Ready to take your career to new heights? Join us at MAPS EMEA Conference from May 12th to 14th in Madrid! Connect with like-minded professionals, learn from thought leaders, and be part of shaping the future of Medical Affairs.     MAPS Iberia (Spain/Portugal) Chapter   #MAPSEMEA24 #MedicalAffairs #MedAffairs #MAPSEvent #Innovation #HealthcareRevolution #Jointhemovement

One of the striking themes of the conversations I had at ISPOR last week was around the industry's heightened commitment to creative, mutually-challenging 🌟 cross-functional working 🌟. There is urgency to get this right across key activities: strategic planning, evidence generation planning, value prop development, patient support programs, and others. Friction occurs because different teams serve different stakeholders and have different goals and KPIs - but the potential rewards for getting it right are huge. Here is some practical guidance in relation to value proposition development 💡 Take time at the beginning of the process for each member of the cross-functional team to understand the role, remit and operating pressures of the other functions 💡 Meet frequently so that challenging conversations around the value proposition can happen directly between functions vs. within functional silos 💡 Provide opportunities to comment on cross-functional work 'agnostically’, i.e. going beyond the narrowest interpretation of responsibilities. This is likely to involve Medical Affairs and Market Access providing input on (and challenging) Commercial assumptions…and vice versa Monte Smith, Mary Lynn Kelley, MBA, Eleonora d'Amore and I recently wrote a white paper on this topic. Lots of practical 'aha' moments inside - drawing on the wisdom of many of our colleagues, including Nandini Hadker. The link is in the comments. Thanks also to Marek R. Rombel.

Just finished a great #subregioneurope team meeting in beautiful Colmar. As General Manager, I find the midpoint of the year critical to take stock and prepare for what’s next. Energy levels are just right: we’re excited by what we can achieve before Q2 closes; Spring has finally sprung, and we know that a well-deserved summer break is coming. This year, we decided to focus on operational robustness as the #redthread of the meeting. When teams are clear about the “𝐰𝐡𝐲” (serving patients) and the “𝐰𝐡𝐚𝐭” (access to innovative medicines), the “𝐡𝐨𝐰” will make a huge difference. How can we get BeiGene’s innovative #medicines to #patients in a broader, faster, and more affordable way across our Region?   It was the perfect time to: ✳ 𝐑𝐞𝐟𝐥𝐞𝐜𝐭 𝐚𝐧𝐝 𝐜𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐞 𝐭𝐡𝐞 𝐭𝐞𝐚𝐦’𝐬 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐦𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞𝐬: we can only prepare for what’s next when we’re fully aware of what we did so far; we can learn from the less positive outcomes and replicate what we excelled at; ✳ 𝐓𝐫𝐚𝐜𝐤 𝐡𝐨𝐰 𝐰𝐞’𝐫𝐞 𝐝𝐨𝐢𝐧𝐠 𝐚𝐠𝐚𝐢𝐧𝐬𝐭 𝐭𝐡𝐞 𝐠𝐨𝐚𝐥𝐬 𝐰𝐞 𝐬𝐞𝐭: although objectives are not static, they are our performance compass. Are we meeting our ambitions? Can we do more? Or differently? ✳ 𝐌𝐢𝐧𝐝 𝐭𝐡𝐞 𝐠𝐚𝐩: what’s standing between our targets and the current status? Do we need additional skills or enhancement of capabilities? ✳ 𝐄𝐦𝐩𝐨𝐰𝐞𝐫, 𝐞𝐦𝐩𝐨𝐰𝐞𝐫, 𝐚𝐧𝐝 𝐞𝐦𝐩𝐨𝐰𝐞𝐫: each team member is the CEO of his or her role. We all know the destination and the direction of travel. It’s up to each person to chart an individual course. A big thank you to all members of our team. I am certain that our commitment will continue to drive us towards even greater accomplishments, for patients. #cancerhasnoborders #neitherdowe #teamspirit #letsdoit

There is a widely-cited statistic that 9 out of 10 startups fail… Well today, I'm ecstatic to say that HumanFirst is the exception to this rule. I am beyond thrilled to finally share that HumanFirst will be joining ICON plc, the world's leading Clinical Research Organization, propelling our product and mission to a global stage.  __ On a more personal note, being at a company acquired by ICON is really a full-circle moment for me, so I thought I'd share my journey. 🏢My first job out of college was with PRA Health Sciences, a CRO acquired by ICON just minutes after I left. 🏥From PRA, I moved on to Huntsman Cancer Institute, where I coordinated breast and gynecological oncology clinical trials. I found my stride working end-to-end with patients, their medical teams, and families to coordinate every aspect of participation in a clinical research protocol. Here, amidst all the beauty and optimism that clinical research can offer, I also saw first hand the patient (and coordinator) burden of increased clinic visits and complex data collection processes involved in the implementation of research protocols. There was still so much work to be done to center the patient experience and increase trial efficiency. In the end, this role was immensely rewarding, but I knew there were other ways that I could make an impact in patient lives, and I was just getting started. 🧑💻Fast forward 6 months, I completely switched careers, learned to code, and was hired as a product engineer at HumanFirst, a series A startup poised to revolutionize patient-centered research. Here, I was able to use my industry knowledge to help build a product that would directly impact clinical research processes to improve the lives of humans inside and out of study participation. Being on this small but mighty team — rallying around unlocking better research for all humans, faster, through enabling precision measures in research – has been the highlight of my professional life thus far. Long live the magic we made. So today, as we announce this exciting new future for HumanFirst with ICON, I want to emphasize how beyond proud I am of what we have built and are continuing to build and know that ICON will be the perfect partner to amplify and expand our ability to accelerate patient-centered research. I guess ICON finally caught me 😉 __ Read more about the journey in STAT News : https://lnkd.in/etwkJes9 Check out the HumanFirst webpage on ICON’s site: https://lnkd.in/eA49_QEn

Welcome to the team, Lyptus! For further information on how Lyptus workforce solutions can help you to achieve your goals, speak to Paul Chiswick

Join Parexel and The Medical Affairs Company (TMAC) colleagues in San Juan, Puerto Rico for the MAPS 2024 Americas Annual Meeting — the largest global gathering of Medical Affairs Professionals. Don't miss Kyle Kennedy at the MedTech session: 𝘔𝘪𝘴𝘴𝘪𝘰𝘯 𝘗𝘰𝘴𝘴𝘪𝘣𝘭𝘦: 𝘉𝘶𝘪𝘭𝘥𝘪𝘯𝘨 𝘈 𝘔𝘦𝘥𝘪𝘤𝘢𝘭 𝘈𝘧𝘧𝘢𝘪𝘳𝘴 𝘍𝘶𝘯𝘤𝘵𝘪𝘰𝘯 𝘧𝘳𝘰𝘮 𝘵𝘩𝘦 𝘎𝘳𝘰𝘶𝘯𝘥 𝘜𝘱. Within MedTech (comprised of Device & Diagnostics), the Medical Affairs team is very commonly lean or emerging. And as evidence requirements within Med Tech continue to increase, payor requirements shift, and the overall landscape becomes increasingly competitive, there is an increasing need for a robust Medical Affairs function to serve the business needs. This session is designed to address how to equip medical affairs with the right resources and infrastructure to better demonstrate value across the organization.

Reagan Barnett, Ph.D, BCMAS, Medical Science Liaison, Medical Affairs at Guardant Health, shared her experience working with us: "We wanted to invest in developing a platform to help better visualize our data for both internal and external uses, and we are very glad we chose to collaborate with The Hyve. They have been extraordinary partners in helping us develop personalized solutions for our data, problem-solving, and helping us realize our vision. We look forward to our continued relationship and what we will create together." Curious about how we can help your organization unlock the full potential of your data? Discover more about our cBioPortal services and how we can support your needs. Visit our page to learn more: https://lnkd.in/eUPtpVKK. #ClientFeedback #DataVisualization #PersonalizedSolutions #cBioPortal #Innovation #Collaboration #HealthcareData

🚀 What makes an Advisory Board Meeting truly successful? #advisoryboards are a gold standard for collecting valuable medical insights. Especially if you are planning for a #pharmalaunch or a #medicaldevice launch in a new market. Planning and executing an advisory board requires good strategy and content. An advisory board's outcome can be used to steer the direction of a launch toward success if done well. At NSinga Consultancy, we know the impact of seamless planning, especially when it comes to meetings in Asia. From strategic insights to flawless execution, we make your next advisory board experience exceptional. 💡 Need expertise for your upcoming meeting? 👉 Reach out: [email protected]

Looking forward meeting you next week at the EPA congres in Amsterdam.  "Please reach out to our team to discuss Market Access opportunities in the BENELUX region" Melanie van Riemsdijk (Market Access Director Netherlands) Marieke Schurer (Market Access Manager Netherlands) Sven Tops (Market Access Director - Managing Partner) Learn more about Axtalis: axtalis.com #Axtalis #MarketAccess #MedicalAffairs #regulatoryaffairs